Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

July 01, 2006 (Vol. 26, No. 13)

Combating the R&D Productivity Decline

Can Big Pharma Reverse the Trend?

  • Pharmaceutical productivity is down, partly because of the industry&#8217s own inefficiencies, according to Robert Ruffolo, Ph.D., president, R&D, Wyeth Pharmaceuticals (www.wyeth.com), who spoke at the recent &#34Scrip R&D Productivity Summit&#34 in London. The productivity issue is a serious concern to professionals in the biotech and pharmaceutical industries and is ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.